In the last trading session, 88609.0 shares of the BioVie Inc (NASDAQ:BIVI) were traded, and its beta was 1.21. Most recently the company’s share price was $1.03, and it changed around $0.0 or 0.00% from the last close, which brings the market valuation of the company to $19.12M. BIVI currently trades at a discount to its 52-week high of $7.50, offering almost -628.16% off that amount. The share price’s 52-week low was $0.62, which indicates that the current value has risen by an impressive 39.81% since then.
BioVie Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended BIVI as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. BioVie Inc is expected to report earnings per share of -0.36 for the current quarter.
BioVie Inc (NASDAQ:BIVI) trade information
The rise to weekly highs of 1.0800 on recent trading dayincreased the stock’s daily price by 4.63%. On the other hand, BioVie Inc (NASDAQ:BIVI) is 15.19% up in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 5.73%.
BIVI Dividends
BioVie Inc’s next quarterly earnings report is expected to be released in June.
SABBY MANAGEMENT, LLC, with 0.8112% or 0.73 million shares worth $0.29 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 72.47 shares worth $74643.0, making up 0.39% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 48.21 shares worth around $49655.0, which represents about 0.26% of the total shares outstanding.
